Belcher Vernee N, Fried Terri R, Agostini Joseph V, Tinetti Mary E
Department of Internal Medicine, Yale School of Medicine, New Haven, CT 06520-8025, USA.
J Gen Intern Med. 2006 Apr;21(4):298-303. doi: 10.1111/j.1525-1497.2006.00329.x.
Medication decision making is complex, particularly for older patients with multiple conditions for whom benefits may be uncertain and health priorities may be variable. While patient input would seem important in the face of this uncertainty and variability, little is known about older patients' views of involvement in medication decision making.
To explore the views of older adults regarding participation in medication decision making.
Qualitative study.
Fifty-one persons at least 65 years old who consumed at least one medication were recruited from 3 senior centers and 4 physicians' offices.
One-on-one interviews were conducted to uncover participants' perceptions of medication-related decision making through semistructured, open-ended questions. Themes were compared according to the constant comparative method of analysis.
The predominant theme that emerged was the variability in perceptions concerning whether it was possible or desirable for patients to participate in prescribing decisions. For some participants, involvement was limited to sharing information. Physician and system factors that were felt to facilitate or impede patient participation included communication skills, the expanding number of medications available, multiple physicians prescribing for the same patient, and a focus on treating numbers. Perceived lack of knowledge, low self-efficacy, and fear were the patient factors mentioned. Both the presence and absence of trust in the prescribing physician were seen as alternatively impeding and enhancing patient participation. Only 1 participant explicitly mentioned patient preference, a cornerstone of shared decision making.
While evolution to greater patient involvement in medication decision making may be possible, and desirable to some older patients, findings suggest that the transition will be challenging.
药物治疗决策很复杂,尤其是对于患有多种疾病的老年患者,他们的获益可能不确定,健康优先事项也可能各不相同。面对这种不确定性和多样性,患者的参与似乎很重要,但对于老年患者参与药物治疗决策的看法却知之甚少。
探讨老年人对参与药物治疗决策的看法。
定性研究。
从3个老年中心和4个医生办公室招募了51名至少65岁且至少服用一种药物的人。
通过半结构化、开放式问题进行一对一访谈,以揭示参与者对与药物相关决策的看法。根据持续比较分析法对主题进行比较。
出现的主要主题是患者参与处方决策是否可行或可取的看法存在差异。对于一些参与者来说,参与仅限于分享信息。被认为有助于或阻碍患者参与的医生和系统因素包括沟通技巧、可用药物数量的增加、多名医生为同一患者开处方以及对治疗数据的关注。提到的患者因素包括知识不足、自我效能感低和恐惧。对开处方医生的信任与否,都被视为阻碍或促进患者参与的因素。只有1名参与者明确提到了患者偏好,这是共同决策的基石。
虽然让患者更多地参与药物治疗决策的转变可能是可行的,并且对一些老年患者来说是可取的,但研究结果表明,这种转变将具有挑战性。